EX-32.1 5 ctso-20240930xex32d1.htm EX-32.1

Exhibit 32.1

CERTIFICATION OF

PRINCIPAL EXECUTIVE OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT of 2002

Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, I, Phillip Chan, Chief Executive Officer of CytoSorbents Corporation, hereby certify, that, to my knowledge:

1. | The Quarterly Report on Form 10-Q for the quarter ended September 30, 2024 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. | The information contained in such Quarterly Report on Form 10-Q for the quarter ended September 30, 2024, fairly presents, in all material respects, the financial condition and results of operations of CytoSorbents Corporation.

​

Date: November 7, 2024 |  | ​
| ​ | ​
CYTOSORBENTS CORPORATION | ​ | ​
​ | ​ | ​
By: | /s/ Phillip P. Chan | ​ | ​
Phillip Chan | ​ | ​
Chief Executive Officer | ​ | ​

​